{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:48:04Z","timestamp":1793015284013,"version":"4.5.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Cytation TM Cell Imaging Multi-Mode Reader"},{"name":"Multi-User Equipment Program","award":["#15\/06134-4"],"award-info":[{"award-number":["#15\/06134-4"]}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Brazilian foundations: Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo (the S\u00e3o Paulo Research Foundation\u2014FAPESP\u2014Grant","award":["15\/04194-0"],"award-info":[{"award-number":["15\/04194-0"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfco e Tecnol\u00f3gico (the Brazilian National Council for Scientific and Technological Development\u2014CNPq\u2014Grant","award":["#431465\/2016-9"],"award-info":[{"award-number":["#431465\/2016-9"]}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["#18\/03051-9"],"award-info":[{"award-number":["#18\/03051-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["#18\/23559-7"],"award-info":[{"award-number":["#18\/23559-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["#19\/10003-3"],"award-info":[{"award-number":["#19\/10003-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunomodulation has been considered an important approach in the treatment of malignant tumours. However, the modulation of innate immune cells remains an underexplored tool. Studies from our group demonstrated that the Phoneutria nigriventer spider venom (PnV) administration increased the infiltration of macrophage in glioblastoma, in addition to decreasing the tumour size in a preclinical model. The hypothesis that PnV would be modulating the innate immune system led us to the main objective of the present study: to elucidate the effects of PnV and its purified fractions on cultured macrophages. Results showed that PnV and the three fractions activated macrophages differentiated from bone marrow precursors. Further purification generated 23 subfractions named low weight (LW-1 to LW-12) and high weight (HW-1 to HW-11). LW-9 presented the best immunomodulatory effect. Treated cells were more phagocytic, migrated more, showed an activated morphological profile and induced an increased cytotoxic effect of macrophages on tumour cells. However, while M1-controls (LPS) increased IL-10, TNF-alpha and IL-6 release, PnV, fractions and subfractions did not alter any cytokine, with the exception of LW-9 that stimulated IL-10 production. These findings suggest that molecules present in LW-9 have the potential to be used as immunoadjuvants in the treatment of cancer.<\/jats:p>","DOI":"10.1093\/jb\/mvab020","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T23:34:06Z","timestamp":1613432046000},"page":"51-68","source":"Crossref","is-referenced-by-count":6,"title":["Components from spider venom activate macrophages against glioblastoma cells: new potential adjuvants for anticancer immunotherapy"],"prefix":"10.1093","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3112-3033","authenticated-orcid":false,"given":"Jaqueline","family":"Munhoz","sequence":"first","affiliation":[{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade Estadual de Campinas (UNICAMP). C\u00e2ndido Portinari, 200 - Cidade Universit\u00e1ria, Campinas, S\u00e3o Paulo, 13083-871 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Peron","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP. Av. Bertrand Russel, Campinas, S\u00e3o Paulo, 13083-865, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Pires","family":"Bonfanti","sequence":"additional","affiliation":[{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade Estadual de Campinas (UNICAMP). C\u00e2ndido Portinari, 200 - Cidade Universit\u00e1ria, Campinas, S\u00e3o Paulo, 13083-871 ,","place":["Brazil"]},{"name":"Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP. Av. Bertrand Russel, Campinas, S\u00e3o Paulo, 13083-865, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP. Av. Bertrand Russel, Campinas, S\u00e3o Paulo, 13083-865, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomaz A A","family":"da Rocha-e-Silva","sequence":"additional","affiliation":[{"name":"Faculdade Israelita de Ci\u00eancias da Sa\u00fade Albert Einstein, S\u00e3o Paulo, SP, 05652-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sutti","sequence":"additional","affiliation":[{"name":"Faculdade de Ci\u00eancias M\u00e9dicas, Santa Casa de S\u00e3o Paulo. Dr. Ces\u00e1rio Motta Jr., 61, Vila Buarque, S\u00e3o Paulo, SP, 01221-020, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Thom\u00e9","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP. Av. Bertrand Russel, Campinas, S\u00e3o Paulo, 13083-865, Brazil"},{"name":"Department of Neurology, Thomas Jefferson University, 909 Walnut St #3, Philadelphia, PA, 19107, \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Lu\u00eds","family":"Bombeiro","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP. Av. Bertrand Russel, Campinas, S\u00e3o Paulo, 13083-865, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Barreto","sequence":"additional","affiliation":[{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade Estadual de Campinas (UNICAMP). C\u00e2ndido Portinari, 200 - Cidade Universit\u00e1ria, Campinas, S\u00e3o Paulo, 13083-871 ,","place":["Brazil"]},{"name":"Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP. Av. Bertrand Russel, Campinas, S\u00e3o Paulo, 13083-865, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanbar Mahmoodi","family":"Chalbatani","sequence":"additional","affiliation":[{"name":"Department of Immunology and Biology, TUMS School of Medicine, Poursina Road, Tehran, 1417613151, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Gharagouzloo","sequence":"additional","affiliation":[{"name":"Cancer Institute, Keshavarz Blvd, Tehran University of Medical Science, Tehran , 1419733141,","place":["Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Luiz","family":"Vitorino-Araujo","sequence":"additional","affiliation":[{"name":"Disciplina de Neurocirurgia, Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa de S\u00e3o Paulo. Dona Veridiana, 56 - Higien\u00f3polis, S\u00e3o Paulo - SP, 01238-010, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Verinaud","sequence":"additional","affiliation":[{"name":"Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP. Av. Bertrand Russel, Campinas, S\u00e3o Paulo, 13083-865, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Rap\u00f4so","sequence":"additional","affiliation":[{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade Estadual de Campinas (UNICAMP). C\u00e2ndido Portinari, 200 - Cidade Universit\u00e1ria, Campinas, S\u00e3o Paulo, 13083-871 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"2026041420065881300_mvab020-B1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14740338.2013.795944","article-title":"Cancer immunotherapies, their safety and toxicity","volume":"12","author":"Alatrash","year":"2013","journal-title":"Expert Opin. Drug Saf"},{"key":"2026041420065881300_mvab020-B2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"2026041420065881300_mvab020-B3","first-page":"39","volume-title":"Seminars in Cancer Biology","author":"Burugu","year":"2018"},{"key":"2026041420065881300_mvab020-B4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"2026041420065881300_mvab020-B5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4155\/tde.13.88","article-title":"Cancer immunotherapy: accomplishments to date and future promise","volume":"4","author":"Helmy","year":"2013","journal-title":"Therap. Deliv"},{"key":"2026041420065881300_mvab020-B6","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-15-1433","article-title":"Making better chimeric antigen receptors for adoptive T-cell therapy","volume":"22","author":"Maus","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"2026041420065881300_mvab020-B7","doi-asserted-by":"crossref","first-page":"1533033819831068","DOI":"10.1177\/1533033819831068","article-title":"The emerging world of TCR-T cell trials against cancer: a systematic review","volume":"18","author":"Zhang","year":"2019","journal-title":"Technol. Cancer Res. Treat"},{"key":"2026041420065881300_mvab020-B8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13046-019-1153-8","article-title":"Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment","volume":"38","author":"Looi","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"2026041420065881300_mvab020-B9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/cancers11070915","article-title":"Targeting the immune microenvironment in lymphomas of B-cell origin: from biology to clinical application","volume":"11","author":"Mulder","year":"2019","journal-title":"Cancers"},{"key":"2026041420065881300_mvab020-B10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4049\/jimmunol.1700236","article-title":"Comparison of T cell activities mediated by human TCRs and CARs that use the same recognition domains","volume":"200","author":"Harris","year":"2018","journal-title":"J. Immunol"},{"key":"2026041420065881300_mvab020-B11","first-page":"1","article-title":"Precision therapeutic targeting of human cancer cell motility","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun"},{"key":"2026041420065881300_mvab020-B12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-319-39406-0_9","volume-title":"Apoptosis in Cancer Pathogenesis and Anti-cancer Therapy","author":"Weigert","year":"2016"},{"key":"2026041420065881300_mvab020-B13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","article-title":"Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy","volume":"99","author":"Komohara","year":"2016","journal-title":"Adv. Drug Deliv. Rev"},{"key":"2026041420065881300_mvab020-B14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00441-017-2753-2","article-title":"Partners in crime: neutrophils and monocytes\/macrophages in inflammation and disease","volume":"371","author":"Kumar","year":"2018","journal-title":"Cell Tissue Res"},{"key":"2026041420065881300_mvab020-B15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.4RI1216-516R","article-title":"Engineering macrophages to eat cancer: from \u201cmarker of self\u201d CD47 and phagocytosis to differentiation","volume":"102","author":"Alvey","year":"2017","journal-title":"J. Leukocyte Biol"},{"key":"2026041420065881300_mvab020-B16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"2026041420065881300_mvab020-B17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/imt-2018-0156","article-title":"Re-education of macrophages as a therapeutic strategy in cancer","volume":"11","author":"Kowal","year":"2019","journal-title":"Immunotherapy"},{"key":"2026041420065881300_mvab020-B18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov"},{"key":"2026041420065881300_mvab020-B19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/imt-2016-0135","article-title":"Tumor-associated macrophages: implications in cancer immunotherapy","volume":"9","author":"Petty","year":"2017","journal-title":"Immunotherapy"},{"key":"2026041420065881300_mvab020-B20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"2026041420065881300_mvab020-B21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"2026041420065881300_mvab020-B22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuint.2016.04.005","article-title":"Neuropharmacological effects of Phoneutria nigriventer venom on astrocytes","volume":"96","author":"Rap\u00f4so","year":"2016","journal-title":"Neurochem. Int"},{"key":"2026041420065881300_mvab020-B23","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/jcp.26935","article-title":"Venom of the Phoneutria nigriventer spider alters the cell cycle, viability, and migration of cancer cells","volume":"234","author":"Barreto","year":"2019","journal-title":"J. Cell. Physiol"},{"key":"2026041420065881300_mvab020-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62620-9","article-title":"Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model","volume":"10","author":"Bonfanti","year":"2020","journal-title":"Sci. Rep"},{"key":"2026041420065881300_mvab020-B25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/s12935-020-01643-8","article-title":"Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+\/K+-ATPase \u03b22: potential molecular entities to treat invasive brain cancer","volume":"20","author":"Barreto","year":"2020","journal-title":"Cancer Cell Int"},{"key":"2026041420065881300_mvab020-B26","doi-asserted-by":"crossref","first-page":"e15263","DOI":"10.1371\/journal.pone.0015263","article-title":"A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells","volume":"5","author":"Marim","year":"2010","journal-title":"PLoS One"},{"key":"2026041420065881300_mvab020-B27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1012662423863","article-title":"Establishment and partial characterization of a continuous human malignant glioma cell line: NG97","volume":"21","author":"Grippo","year":"2001","journal-title":"Cell. Mol. Neurobiol."},{"key":"2026041420065881300_mvab020-B28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10571-005-4959-1","article-title":"Immunophenotypic and ultrastructural validation of a new human glioblastoma cell line","volume":"25","author":"Schenka","year":"2005","journal-title":"Cell. Mol. Neurobiol"},{"key":"2026041420065881300_mvab020-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-5-13","article-title":"Morphological characterization of a human glioma cell line","volume":"5","author":"Machado","year":"2005","journal-title":"Cancer Cell Int."},{"key":"2026041420065881300_mvab020-B30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1471-2407-8-291","article-title":"Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro","volume":"8","author":"Machado","year":"2008","journal-title":"BMC Cancer"},{"key":"2026041420065881300_mvab020-B31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jemt.20653","article-title":"Ultrastructural characterization of the new NG97ht human-derived glioma cell line using two different electron microscopy technical procedures","volume":"72","author":"Machado","year":"2009","journal-title":"Microsc. Res. Tech"},{"key":"2026041420065881300_mvab020-B32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-61779-527-5_14","volume-title":"Leucocytes","author":"Nicola","year":"2012"},{"key":"2026041420065881300_mvab020-B33","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.4049\/jimmunol.1401893","article-title":"miR-24, miR-30b, and miR-142-3p regulate phagocytosis in myeloid inflammatory cells","volume":"194","author":"Naqvi","year":"2015","journal-title":"J. Immunol"},{"key":"2026041420065881300_mvab020-B34","doi-asserted-by":"crossref","first-page":"e0146622","DOI":"10.1371\/journal.pone.0146622","article-title":"Immunological characterization of whole tumour lysate-loaded dendritic cells for cancer immunotherapy","volume":"11","author":"Rainone","year":"2016","journal-title":"PLoS One"},{"key":"2026041420065881300_mvab020-B35","first-page":"81","article-title":"The macrophage is a key factor in renal injuries caused by glomerular hyperfiltration","volume":"65","author":"Sasaki","year":"2011","journal-title":"Acta Med. Okayama"},{"key":"2026041420065881300_mvab020-B36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcpa.2014.07.003","article-title":"Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats","volume":"151","author":"Pierezan","year":"2014","journal-title":"J. Comp. Pathol"},{"key":"2026041420065881300_mvab020-B37","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-\u03b1: central factors in the altered cytokine network of uremia\u2014the good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"key":"2026041420065881300_mvab020-B38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/477526a","article-title":"4 ways to fix the clinical trial: clinical trials are crumbling under modern economic and scientific pressures. Nature looks at ways they might be saved","volume":"477","author":"Ledford","year":"2011","journal-title":"Nature"},{"key":"2026041420065881300_mvab020-B39","first-page":"1562","article-title":"Natural products as treatment against cancer: a historical and current vision","volume":"4","author":"Amaral","year":"2019","journal-title":"Clin. Oncol"},{"key":"2026041420065881300_mvab020-B40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bcp.2016.07.011","article-title":"A novel real time imaging platform to quantify macrophage phagocytosis","volume":"116","author":"Kapellos","year":"2016","journal-title":"Biochem. Pharmacol"},{"key":"2026041420065881300_mvab020-B41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"2026041420065881300_mvab020-B42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mrrev.2012.08.001","article-title":"In vitro cell migration and invasion assays","volume":"752","author":"Kramer","year":"2013","journal-title":"Mutat. Res. Rev. Mutat. Res"},{"key":"2026041420065881300_mvab020-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"},{"key":"2026041420065881300_mvab020-B44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ijc.28736","article-title":"Tumor-associated macrophages exhibit pro-and anti-inflammatory properties by which they impact on pancreatic tumorigenesis","volume":"135","author":"Helm","year":"2014","journal-title":"Int. J. Cancer"},{"key":"2026041420065881300_mvab020-B45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mc.22750","article-title":"Pro-inflammatory M1 Macrophage enhances metastatic potential of ovarian cancer cells through NF-\u03baB activation","volume":"57","author":"Cho","year":"2018","journal-title":"Mol. Carcinogene"},{"key":"2026041420065881300_mvab020-B46","first-page":"263","article-title":"Much more than M1 and M2 macrophages, there are also CD169+ and TCR+ macrophages","volume":"6","author":"Ch\u00e1vez-Gal\u00e1n","year":"2015","journal-title":"Front. Immunol"},{"key":"2026041420065881300_mvab020-B47","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1378\/chest.12-1467","article-title":"Organizing pneumonia as a side effect of ipilimumab treatment of melanoma","volume":"143","author":"Barjaktarevic","year":"2013","journal-title":"Chest"},{"key":"2026041420065881300_mvab020-B48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11684-018-0657-5","article-title":"Activation of phagocytosis by immune checkpoint blockade","volume":"12","author":"Li","year":"2018","journal-title":"Front. Med"},{"key":"2026041420065881300_mvab020-B49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/joim.12470","article-title":"The immune system and cancer evasion strategies: therapeutic concepts","volume":"279","author":"Muenst","year":"2016","journal-title":"J. Int. Med"},{"key":"2026041420065881300_mvab020-B50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fimmu.2017.00828","article-title":"Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo-and immunotherapies","volume":"8","author":"Genard","year":"2017","journal-title":"Front. Immunol"},{"key":"2026041420065881300_mvab020-B51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","article-title":"Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways","volume":"26","author":"Zhou","year":"2014","journal-title":"Cell. Signall"},{"key":"2026041420065881300_mvab020-B52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"2026041420065881300_mvab020-B53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1074\/jbc.274.2.559","article-title":"Integrin-associated protein is a ligand for the P84 neural adhesion molecule","volume":"274","author":"Jiang","year":"1999","journal-title":"J. Biol. Chem"},{"key":"2026041420065881300_mvab020-B54","doi-asserted-by":"crossref","first-page":"e0153550","DOI":"10.1371\/journal.pone.0153550","article-title":"Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"2026041420065881300_mvab020-B55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"2026041420065881300_mvab020-B56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2018","journal-title":"Nat. Immunol"}],"container-title":["The Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jb\/advance-article-pdf\/doi\/10.1093\/jb\/mvab020\/36647193\/mvab020.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/170\/1\/51\/40429164\/mvab020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/170\/1\/51\/40429164\/mvab020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:13:10Z","timestamp":1776211990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jb\/article\/170\/1\/51\/6143041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2,18]]},"published-print":{"date-parts":[[2021,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/jb\/mvab020","relation":{},"ISSN":["0021-924X","1756-2651"],"issn-type":[{"value":"0021-924X","type":"print"},{"value":"1756-2651","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,2,18]]}}}